New York, New York -(Newsfile Corp. -26 January 2025) – WHY: The law firm Rosen, a law firm for investor rights, reminds the buyers of ordinary shares of Kyverna Therapeutics, Inc. (Nasdaq: Kytx) in accordance with the public offer of Kyverna (NASDAQ: Kytx) carried out on February 8, 2024 (the “IPO”), carried out on February 8, 2024 (The “IPO”)) and/or truck). the important one February 7, 2025 Lead plaintiff.
Well and: If you have bought Kyverna regular shares, you may be entitled to compensation without paying the pocket fees or costs through a destination.
What to do next: To connect the Kyverna collection, visit https://rosenegal.com/submit-form/?case_id=32239 or call Phillip Kim, ESQ. Free of free 866-767-3653 or send an email to cays@rosenlegal.com to get information about the class action. A class action has already been submitted. If you want to act as a senior plaintiff, you have to move the court February 7, 2025 at the latest. A senior plaintiff is a representative party that acts on behalf of other class members in the instructions of the legal dispute.
Why Rose Act: We encourage investors to select qualified consultants with a success story of success in leadership roles. Companies that issue communications often have no comparable experiences, resources or sensible recognition of peers. Many of these companies do not actually argue on securities lawsuits, but are only intermediate traders who refer clients or work with law firms that actually count cases. Be wise when choosing a lawyer. The Rosenan law firm represents investors around the world and concentrates in practice on collective suits of the securities and the shareholder derivative disputes. At that time, the Rosen law firm received the biggest comparison to the class action against a Chinese company. The Rosen law firm was classified in 1st place by the ISS value paper class action (Wa 🙂 Services for the number of collecting plates in 2017. The company has been classified every year since 2013 to the top 4 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over 438 million US dollars for investors. In 2020, the founding partner Laurence Rosen from Law360 was appointed the plaintiff’s titanium. Many lawyers from the law firm were recognized by Lawdragon and super lawyers.
Details of the case: According to the lawsuit, the registration declaration and the prospectus was used to bring about the IPO of Kyverna, and/or omitted facts on the results of the ongoing assessment of KYV-101, Kyverna’s main product candidate, in clinical studies. In particular, Kyverna advertised the “improvement” of the patients in certain indicators, while they had disadvantage not adverse data on one of the attempts in Kyverna that Kyverna was disadvantageous at the time of the IPO. When the actual details entered the market, the lawsuit claims that investors had suffered compensation.
To join the Kyverna collection, visit https://rosenegal.com/submit-form/?case_id=32239 or call Phillip Kim, ESQ. Free of free 866-767-3653 or send an email to cays@rosenlegal.com to get information about the class action.
No class was certified. Until a class is certified, they are not represented by a lawyer unless they keep one. You can choose a lawyer of your choice. You can also remain an absent class member and do nothing at this point. The ability of an investor to participate in a potential future recovery does not depend on the senior plaintiff.
Follow us for updates at LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firpr or on Facebook (nasdaq: /www.facebookbook .com/rosenlawfirm/.
Lawyer advertising. Earlier results do not guarantee a similar result.
————————–
Contact information:
To display the source version of this press release, please visit https://www.newsfilecorp.com/release/238474